home / stock / lxxgf / lxxgf news

LXXGF News and Press, Lexagene Holdings From 07/29/22

Stock Information
Company Name: Lexagene Holdings
Stock Symbol: LXXGF
Market: OTC
Website: lexagene.com
Menu
LXXGF LXXGF Quote LXXGF Short LXXGF News LXXGF Articles LXXGF Message Board
Get LXXGF Alerts

News, Short Squeeze, Breakout and More Instantly...
LXXGF - LexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to Employees

BEVERLY, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based s...
LXXGF - LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections

BEVERLY, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based s...

LXXGF - LexaGene Provides MCTO Update

BEVERLY, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based s...

LXXGF - LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections

BEVERLY, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab System for automated, multiplexing PCR...
LXXGF - LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin

BEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated, multiplexi...

LXXGF - LexaGene Announces Management Cease Trade Order

BEVERLY, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”) announces, further to its news release on June 28, 2022, the Company has been granted a management cease trade...

LXXGF - LexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings

BEVERLY, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (“ LexaGene ” or the “ Company ”) announces that it has filed an initial registration statement with the United States Securities and Exchange Commission (...
LXXGF - LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health

BEVERLY, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is ...

LXXGF - LexaGene Successfully Completes CRADA with US Army

BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System , a fully automated r...

LXXGF - LexaGene announces multi-system purchase from a veterinary lab

Molecular diagnostics company, LexaGene (OTCQB:LXXGF) announces a corporate veterinary reference laboratory has purchased 3 MiQLab® Systems for one of their many locations. Dr. Jack Regan, CEO and Founder stated, “Testing in the veterinary industry is domi...
Previous 10 Next 10